Taikang Asset Management Hong Kong Co Ltd trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 26.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,760 shares of the medical equipment provider's stock after selling 4,502 shares during the period. Taikang Asset Management Hong Kong Co Ltd's holdings in Intuitive Surgical were worth $6,320,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. Apexium Financial LP grew its position in Intuitive Surgical by 13.5% in the first quarter. Apexium Financial LP now owns 472 shares of the medical equipment provider's stock valued at $234,000 after acquiring an additional 56 shares during the last quarter. Mirova boosted its position in shares of Intuitive Surgical by 4.1% during the 1st quarter. Mirova now owns 14,267 shares of the medical equipment provider's stock valued at $7,066,000 after purchasing an additional 564 shares in the last quarter. Synovus Financial Corp grew its position in shares of Intuitive Surgical by 36.9% during the 1st quarter. Synovus Financial Corp now owns 3,492 shares of the medical equipment provider's stock worth $1,729,000 after buying an additional 941 shares during the period. ICONIQ Capital LLC lifted its position in shares of Intuitive Surgical by 16.3% during the 1st quarter. ICONIQ Capital LLC now owns 1,930 shares of the medical equipment provider's stock valued at $956,000 after acquiring an additional 270 shares during the period. Finally, Campbell & CO Investment Adviser LLC boosted its stake in Intuitive Surgical by 125.4% during the first quarter. Campbell & CO Investment Adviser LLC now owns 3,778 shares of the medical equipment provider's stock worth $1,871,000 after acquiring an additional 2,102 shares in the last quarter. Institutional investors own 83.64% of the company's stock.
Intuitive Surgical Stock Performance
Shares of ISRG stock traded up $2.69 during mid-day trading on Thursday, hitting $473.84. The company's stock had a trading volume of 1,548,672 shares, compared to its average volume of 1,988,124. The business has a 50-day moving average price of $501.89 and a 200 day moving average price of $519.66. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a market cap of $169.86 billion, a price-to-earnings ratio of 70.01, a PEG ratio of 4.94 and a beta of 1.59.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the company earned $1.78 earnings per share. Intuitive Surgical's revenue was up 21.4% on a year-over-year basis. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Analyst Ratings Changes
Several brokerages have issued reports on ISRG. Wells Fargo & Company increased their price target on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Piper Sandler reaffirmed an "overweight" rating and set a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. UBS Group lifted their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a report on Wednesday, July 23rd. Finally, Citigroup reaffirmed a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Thirteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $595.95.
Get Our Latest Stock Analysis on ISRG
Insider Buying and Selling
In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Gary S. Guthart sold 2,800 shares of the stock in a transaction that occurred on Monday, July 28th. The shares were sold at an average price of $495.24, for a total value of $1,386,672.00. Following the transaction, the insider owned 18,520 shares of the company's stock, valued at $9,171,844.80. This represents a 13.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,839 shares of company stock worth $7,896,972. 0.70% of the stock is owned by corporate insiders.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.